Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Carl Blomqvist

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Finland

Physiology

Genetic Predisposition to Disease

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Ahlin Cecilia; Zhou Wenjing; Holmqvist Marit; Holmberg Lars; Nilsson Cecilia; Jirström Karin; Blomqvist Carl; Amini Rose-Marie; Fjällskog Marie-Louise
Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer.
Penttinen Heidi; Nikander Riku; Blomqvist Carl; Luoto Riitta; Saarto Tiina
Recruitment of breast cancer survivors into a 12-month supervised exercise intervention is feasible.
Jiang Hai; Reinhardt H Christian; Bartkova Jirina; Tommiska Johanna; Blomqvist Carl; Nevanlinna Heli; Bartek Jiri; Yaffe Michael B; Hemann Michael T
The combined status of ATM and p53 link tumor development with therapeutic response.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Carl Blomqvist (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Ahlin Cecilia; Zhou Wenjing; Holmqvist Marit; Holmberg Lars; Nilsson Cecilia; Jirström Karin; Blomqvist Carl; Amini Rose-Marie; Fjällskog Marie-Louise
Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(9):2501-6.
2009: Penttinen Heidi; Nikander Riku; Blomqvist Carl; Luoto Riitta; Saarto Tiina
Recruitment of breast cancer survivors into a 12-month supervised exercise intervention is feasible.
Contemporary clinical trials 2009;30(5):457-63.
2009: Jiang Hai; Reinhardt H Christian; Bartkova Jirina; Tommiska Johanna; Blomqvist Carl; Nevanlinna Heli; Bartek Jiri; Yaffe Michael B; Hemann Michael T
The combined status of ATM and p53 link tumor development with therapeutic response.
Genes & development 2009;23(16):1895-909.
2009: Heikkinen Tuomas; Kärkkäinen Hanni; Aaltonen Kirsimari; Milne Roger L; Heikkilä Päivi; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli
The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(9):3214-22.
2009: Monazzam Azita; Razifar Pasha; Ide Susan; Rugaard Jensen Michael; Josephsson Raymond; Blomqvist Carl; Langström Bengt; Bergström Mats
Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
Nuclear medicine and biology 2009;36(3):335-42.
2009: Aaltonen K; Amini R-M; Heikkilä P; Aittomäki K; Tamminen A; Nevanlinna H; Blomqvist C
High cyclin B1 expression is associated with poor survival in breast cancer.
British journal of cancer 2009;100(7):1055-60.
2009: Nilsson G; Holmberg L; Garmo H; Terent A; Blomqvist C
Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke.
British journal of cancer 2009;100(5):811-6.
2009: Fletcher Olivia; Johnson Nichola; Dos Santos Silva Isabel; Kilpivaara Outi; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli; Wasielewski Marijke; Meijers-Heijerboer Hanne; Broeks Annegien; Schmidt Marjanka K; Van't Veer Laura J; Bremer Michael; Dörk Thilo; Chekmariova Elena V; Sokolenko Anna P; Imyanitov Evgeny N; Hamann Ute; Rashid Muhammad U; Brauch Hiltrud; Justenhoven Christina; Ashworth Alan; Peto Julian
Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(1):230-4.
2009: Sjöström-Mattson Johanna; Von Boguslawski Kristina; Bengtsson Nils-Olof; Mjaaland Ingvil; Salmenkivi Kaisa; Blomqvist Carl
The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.
Acta oncologica (Stockholm, Sweden) 2009;48(8):1137-43.
2008: Bartkova Jirina; Tommiska Johanna; Oplustilova Lenka; Aaltonen Kirsimari; Tamminen Anitta; Heikkinen Tuomas; Mistrik Martin; Aittomäki Kristiina; Blomqvist Carl; Heikkilä Päivi; Lukas Jiri; Nevanlinna Heli; Bartek Jiri
Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.
Molecular oncology 2008;2(4):296-316.
2008: Lempiäinen Anna; Stenman Ulf-Håkan; Blomqvist Carl; Hotakainen Kristina
Free beta-subunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer.
Clinical chemistry 2008;54(11):1840-3.
2008: Saarto Tiina; Vehmanen Leena; Blomqvist Carl; Elomaa Inkeri
Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(26):4289-95.
2008: Fagerholm Rainer; Hofstetter Barbara; Tommiska Johanna; Aaltonen Kirsimari; Vrtel Radek; Syrjäkoski Kirsi; Kallioniemi Anne; Kilpivaara Outi; Mannermaa Arto; Kosma Veli-Matti; Uusitupa Matti; Eskelinen Matti; Kataja Vesa; Aittomäki Kristiina; von Smitten Karl; Heikkilä Päivi; Lukas Jiri; Holli Kaija; Bartkova Jirina; Blomqvist Carl; Bartek Jiri; Nevanlinna Heli
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer.
Nature genetics 2008;40(7):844-53.
2008: Aaltonen Kirsimari; Blomqvist Carl; Amini Rose-Marie; Eerola Hannaleena; Aittomäki Kristiina; Heikkilä Päivi; Nevanlinna Heli
Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):1976-83.
2008: Tommiska J; Bartkova J; Heinonen M; Hautala L; Kilpivaara O; Eerola H; Aittomäki K; Hofstetter B; Lukas J; von Smitten K; Blomqvist C; Ristimäki A; Heikkilä P; Bartek J; Nevanlinna H
The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.
Oncogene 2008;27(17):2501-6.
2008: Kivioja Aarne H; Blomqvist Carl; Hietaniemi Kalevi; Trovik Clement; Walloe Anders; Bauer Henrik C F; Jorgensen Peter H; Bergh Peter; Follerås Gunnar
Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years.
Acta orthopaedica 2008;79(1):86-93.
2008: Sampo M; Tarkkanen M; Huuhtanen R; Tukiainen E; Böhling T; Blomqvist C
Impact of the smallest surgical margin on local control in soft tissue sarcoma.
The British journal of surgery 2008;95(2):237-43.
2008: Kilpivaara Outi; Rantanen Matias; Tamminen Anitta; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli
Comprehensive analysis of NuMA variation in breast cancer.
BMC cancer 2008;8():71.
2008: Eerola Hannaleena; Heinonen Mira; Heikkilä Päivi; Kilpivaara Outi; Tamminen Anitta; Aittomäki Kristiina; Blomqvist Carl; Ristimäki Ari; Nevanlinna Heli
Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families.
Breast cancer research : BCR 2008;10(1):R17.
2008: Onay Ummiye V; Aaltonen Kirsimari; Briollais Laurent; Knight Julia A; Pabalan Noel; Kilpivaara Outi; Andrulis Irene L; Blomqvist Carl; Nevanlinna Heli; Ozcelik Hilmi
Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk.
BMC cancer 2008;8():6.
2007: Heinonen Mira; Fagerholm Rainer; Aaltonen Kirsimari; Kilpivaara Outi; Aittomäki Kristiina; Blomqvist Carl; Heikkilä Päivi; Haglund Caj; Nevanlinna Heli; Ristimäki Ari
Prognostic role of HuR in hereditary breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6959-63.
2007: Schmidt Marjanka K; Reincke Scarlett; Broeks Annegien; Braaf Linde M; Hogervorst Frans B L; Tollenaar Rob A E M; Johnson Nichola; Fletcher Olivia; Peto Julian; Tommiska Johanna; Blomqvist Carl; Nevanlinna Heli A; Healey Catherine S; Dunning Alison M; Pharoah Paul D P; Easton Douglas F; Dörk Thilo; Van't Veer Laura J;
Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.
Cancer research 2007;67(19):9584-90.
2007: Ahlin C; Aaltonen K; Amini R-M; Nevanlinna H; Fjällskog M-L; Blomqvist C
Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut-off values?
Histopathology 2007;51(4):491-8.
2007: Nyman Heidi; Adde Magdalena; Karjalainen-Lindsberg Marja-Liisa; Taskinen Minna; Berglund Mattias; Amini Rose-Marie; Blomqvist Carl; Enblad Gunilla; Leppä Sirpa
Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.
Blood 2007;109(11):4930-5.
2007: Villman Kenneth; Ohd John F; Lidbrink Elisabet; Malmberg Lena; Lindh Birgitta; Blomqvist Carl; Nordgren Hans; Bergh Jonas; Bergström Daniel; Ahlgren Johan
A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer.
European journal of cancer (Oxford, England : 1990) 2007;43(7):1153-60.
2007: Pylkäs Katri; Tommiska Johanna; Syrjäkoski Kirsi; Kere Juha; Gatei Magtouf; Waddell Nicola; Allinen Minna; Karppinen Sanna-Maria; Rapakko Katrin; Kääriäinen Helena; Aittomäki Kristiina; Blomqvist Carl; Mustonen Aki; Holli Kaija; Khanna Kum Kum; Kallioniemi Olli-Pekka; Nevanlinna Heli; Winqvist Robert
Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer.
Carcinogenesis 2007;28(5):1040-5.
2007: Wilking N; Lidbrink E; Wiklund T; Erikstein B; Lindman H; Malmström P; Kellokumpu-Lehtinen P; Bengtsson N-O; Söderlund G; Anker G; Wist E; Ottosson S; Salminen E; Ljungman P; Holte H; Nilsson J; Blomqvist C; Bergh J
Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):694-700.
2007: Svarvar Catarina; Böhling Tom; Berlin Orjan; Gustafson Pelle; Follerås Gunnar; Bjerkehagen Bodil; Domanski Henryk A; Sundby Hall Kirsten; Tukiainen Erkki; Blomqvist Carl;
Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group.
Cancer 2007;109(2):282-91.
2007: Amini Rose-Marie; Aaltonen Kirsimari; Nevanlinna Heli; Carvalho Ricardo; Salonen Laura; Heikkilä Päivi; Blomqvist Carl
Mast cells and eosinophils in invasive breast carcinoma.
BMC cancer 2007;7():165.
2007: Monazzam Azita; Josephsson Raymond; Blomqvist Carl; Carlsson Jörgen; Långström Bengt; Bergström Mats
Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer.
Breast cancer research : BCR 2007;9(4):R45.
2007: Lindman Henrik; Aström Gunnar; Ahlgren Johan; Villman Kenneth; Blomqvist Carl; Nygren Peter; Bergh Jonas
Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer.
Acta oncologica (Stockholm, Sweden) 2007;46(2):165-71.
2006: Svarvar Catarina; Larramendy Marcelo L; Blomqvist Carl; Gentile Massimiliano; Koivisto-Korander Riitta; Leminen Arto; Bützow Ralf; Böhling Tom; Knuutila Sakari
Do DNA copy number changes differentiate uterine from non-uterine leiomyosarcomas and predict metastasis?
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(8):1068-82.
2006: Aaltonen K; Ahlin C; Amini R-M; Salonen L; Fjällskog M-L; Heikkilä P; Nevanlinna H; Blomqvist C
Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides.
British journal of cancer 2006;94(11):1697-702.
2006: Tommiska Johanna; Seal Sheila; Renwick Anthony; Barfoot Rita; Baskcomb Linda; Jayatilake Hiran; Bartkova Jirina; Tallila Jonna; Kaare Milja; Tamminen Anitta; Heikkilä Päivi; Evans D Gareth; Eccles Diana; Aittomäki Kristiina; Blomqvist Carl; Bartek Jiri; Stratton Michael R; Nevanlinna Heli; Rahman Nazneen
Evaluation of RAD50 in familial breast cancer predisposition.
International journal of cancer. Journal international du cancer 2006;118(11):2911-6.
2006: Vehmanen Leena; Elomaa Inkeri; Blomqvist Carl; Saarto Tiina
Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(4):675-80.
2006: Vahteristo Pia; Syrjäkoski Kirsi; Heikkinen Tuomas; Eerola Hannaleena; Aittomäki Kristiina; von Smitten Karl; Holli Kaija; Blomqvist Carl; Kallioniemi Olli-Pekka; Nevanlinna Heli
BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition.
European journal of human genetics : EJHG 2006;14(2):167-72.
2006: Saarilahti Kauko; Arponen Päivi; Vaalavirta Leila; Tenhunen Mikko; Blomqvist Carl
Chemoradiotherapy of anal cancer is feasible in elderly patients: treatment results of mitomycin-5-FU combined with radiotherapy at Helsinki University Central Hospital 1992-2003.
Acta oncologica (Stockholm, Sweden) 2006;45(6):736-42.
2006: Tommiska Johanna; Jansen Laila; Kilpivaara Outi; Edvardsen Hege; Kristensen Vessela; Tamminen Anitta; Aittomäki Kristiina; Blomqvist Carl; Børresen-Dale Anne-Lise; Nevanlinna Heli
ATM variants and cancer risk in breast cancer patients from Southern Finland.
BMC cancer 2006;6():209.
2006: Villman Kenneth; Sjöström Johanna; Heikkilä Reino; Hultborn Ragnar; Malmström Per; Bengtsson Nils-Olof; Söderberg Martin; Saksela Eero; Blomqvist Carl
TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer.
Acta oncologica (Stockholm, Sweden) 2006;45(5):590-6.
2006: Monazzam Azita; Razifar Pasha; Simonsson Martin; Qvarnström Fredrik; Josephsson Raymond; Blomqvist Carl; Långström Bengt; Bergström Mats
Multicellular tumour spheroid as a model for evaluation of [18F]FDG as biomarker for breast cancer treatment monitoring.
Cancer cell international 2006;6():6.
2006: Vahteristo Pia; Yliannala Kristiina; Tamminen Anitta; Eerola Hannaleena; Blomqvist Carl; Nevanlinna Heli
BACH1 Ser919Pro variant and breast cancer risk.
BMC cancer 2006;6():19.
2005: Poikonen P; Sjöström J; Amini R-M; Villman K; Ahlgren J; Blomqvist C
Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer.
British journal of cancer 2005;93(5):515-9.
2005: Saarto T; Taube T; Blomqvist C; Vehmanen L; Elomaa I
Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric study.
Calcified tissue international 2005;77(2):84-90.
2005: Lassus Patrik; Ristimäki Ari; Huuhtanen Riikka; Tukiainen Erkki; Asko-Seljavaara Sirpa; Andersson Leif C; Miettinen Markku; Blomqvist Carl; Haglund Caj; Böhling Tom
Cyclooxygenase-2 expression in human soft-tissue sarcomas is related to epithelial differentation.
Anticancer research 2005;25(4):2669-74.
2005: Tommiska Johanna; Eerola Hannaleena; Heinonen Mira; Salonen Laura; Kaare Milja; Tallila Jonna; Ristimäki Ari; von Smitten Karl; Aittomäki Kristiina; Heikkilä Päivi; Blomqvist Carl; Nevanlinna Heli
Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(14):5098-103.
2005: Villman Kenneth; Blomqvist Carl; Larsson Rolf; Nygren Peter
Predictive value of in vitro assessment of cytotoxic drug activity in advanced breast cancer.
Anti-cancer drugs 2005;16(6):609-15.
2005: Kiuru Maija; Lehtonen Rainer; Eerola Hannaleena; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli; Aaltonen Lauri A; Launonen Virpi
No germline FH mutations in familial breast cancer patients.
European journal of human genetics : EJHG 2005;13(4):506-9.
2005: Leppä S; Saarto T; Vehmanen L; Blomqvist C; Elomaa I
Clodronate treatment influences MMP-2 associated outcome in node positive breast cancer.
Breast cancer research and treatment 2005;90(2):117-25.
2005: Kilpivaara Outi; Bartkova Jirina; Eerola Hannaleena; Syrjäkoski Kirsi; Vahteristo Pia; Lukas Jiri; Blomqvist Carl; Holli Kaija; Heikkilä Päivi; Sauter Guido; Kallioniemi Olli-Pekka; Bartek Jiri; Nevanlinna Heli
Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients.
International journal of cancer. Journal international du cancer 2005;113(4):575-80.
2005: Eerola Hannaleena; Heikkilä Päivi; Tamminen Anitta; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli
Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families.
Breast cancer research : BCR 2005;7(4):R465-9.
2005: Eerola Hannaleena; Heikkilä Päivi; Tamminen Anitta; Aittomäki Kristiina; Blomqvist Carl; Nevanlinna Heli
Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.
Breast cancer research : BCR 2005;7(1):R93-100.
2004: Nilsson-Ihrfelt Elisabeth; Fjällskog Marie-Louise; Liss Anders; Jakobsson Olafur; Blomqvist Carl; Andersson Gerhard
Autobiographical memories in patients treated for breast cancer.
Journal of psychosomatic research 2004;57(4):363-6.
2004: Nilsson-Ihrfelt Elisabeth; Fjällskog Marie-Louise; Blomqvist Carl; Ahlgren Johan; Edlund Per; Hansen Jörgen; Malmberg Lena; Villman Kenneth; Andersson Gerhard
Breast cancer on the Internet: the quality of Swedish breast cancer websites.
Breast (Edinburgh, Scotland) 2004;13(5):376-82.
2004: Vehmanen Leena; Saarto Tiina; Risteli Juha; Risteli Leila; Blomqvist Carl; Elomaa Inkeri
Short-term intermittent intravenous clodronate in the prevention of bone loss related to chemotherapy-induced ovarian failure.
Breast cancer research and treatment 2004;87(2):181-8.
2004: Kilpivaara Outi; Vahteristo Pia; Falck Jacob; Syrjäkoski Kirsi; Eerola Hannaleena; Easton Douglas; Bartkova Jirina; Lukas Jiri; Heikkilä Päivi; Aittomäki Kristiina; Holli Kaija; Blomqvist Carl; Kallioniemi Olli-Pekka; Bartek Jiri; Nevanlinna Heli
CHEK2 variant I157T may be associated with increased breast cancer risk.
International journal of cancer. Journal international du cancer 2004;111(4):543-7.
2004: Vehmanen L; Saarto T; Blomqvist C; Taskinen M-R; Elomaa I
Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids.
British journal of cancer 2004;91(3):476-81.
2004: Carlsson J; Nordgren H; Sjöström J; Wester K; Villman K; Bengtsson N O; Ostenstad B; Lundqvist H; Blomqvist C
HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review.
British journal of cancer 2004;90(12):2344-8.
2004: Leppä Sirpa; Saarto Tiina; Vehmanen Leena; Blomqvist Carl; Elomaa Inkeri
A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):1057-63.
2004: Huusko Pia; Juo Suh-Hang Hank; Gillanders Elizabeth; Sarantaus Laura; Kainu Tommi; Vahteristo Pia; Allinen Minna; Jones MaryPat; Rapakko Katrin; Eerola Hannaleena; Markey Carol; Vehmanen Paula; Gildea Derek; Freas-Lutz Diane; Blomqvist Carl; Leisti Jaakko; Blanco Guillermo; Puistola Ulla; Trent Jeffrey; Bailey-Wilson Joan; Winqvist Robert; Nevanlinna Heli; Kallioniemi Olli-P
Genome-wide scanning for linkage in Finnish breast cancer families.
European journal of human genetics : EJHG 2004;12(2):98-104.
2004: Popov Pentscho; Tukiainen Erkki; Asko-Seljavaara Sirpa; Huuhtanen Riikka; Virolainen Martti; Virkkunen Pekka; Blomqvist Carl
Soft-tissue sarcomas of the upper extremity: surgical treatment and outcome.
Plastic and reconstructive surgery 2004;113(1):222-30; discussion 231-2.
2004: Saarto Tiina; Vehmanen Leena; Virkkunen Pekka; Blomqvist Carl
Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients.
Acta oncologica (Stockholm, Sweden) 2004;43(7):650-6.
2004: Poikonen Paula; Sjöström Johanna; Klaar Sigrid; Nittby Lena Tennvall; Sigurdsson Helgi; Madsen Ebbe Lindegaard; Joensuu Heikki; Blomqvist Carl
Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel.
Acta oncologica (Stockholm, Sweden) 2004;43(2):190-5.
2003: Luoma M-L; Hakamies-Blomqvist L; Sjöström J; Pluzanska A; Ottoson S; Mouridsen H; Bengtsson N-O; Bergh J; Malmström P; Valvere V; Tennvall L; Blomqvist C
Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 2003;39(10):1370-6.
2002: Vahteristo Pia; Bartkova Jirina; Eerola Hannaleena; Syrjäkoski Kirsi; Ojala Salla; Kilpivaara Outi; Tamminen Anitta; Kononen Juha; Aittomäki Kristiina; Heikkilä Päivi; Holli Kaija; Blomqvist Carl; Bartek Jiri; Kallioniemi Olli-P; Nevanlinna Heli
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.
American journal of human genetics 2002;71(2):432-8.
2002: Tynninen O; Sjöström J; von Boguslawski K; Bengtsson N O; Heikkilä R; Malmström P; Ostenstad B; Wist E; Valvere V; Saksela E; Paavonen T; Blomqvist C
Tumour microvessel density as predictor of chemotherapy response in breast cancer patients.
British journal of cancer 2002;86(12):1905-8.
2002: Sjöström Johanna; Blomqvist Carl; von Boguslawski Kristina; Bengtsson Nils-Olof; Mjaaland Ingvil; Malmström Per; Ostenstadt Björn; Wist Erik; Valvere Vahur; Takayama Shinichi; Reed John C; Saksela Eero
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(3):811-6.
2002: Sjöström J; Collan J; von Boguslawski K; Franssila K; Bengtsson N-O; Mjaaland I; Malmström P; Østenstad B; Wist E; Valvere V; Bergh J; Skiöld-Petterson D; Saksela E; Blomqvist C
C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer.
European journal of cancer (Oxford, England : 1990) 2002;38(4):535-42.
2002: Hernberg Micaela; Virkkunen Pekka; Maasilta Paula; Keyriläinen Jani; Blomqvist Carl; Bergh Jonas; Wiklund Tom
Pulmonary toxicity after radiotherapy in primary breast cancer patients: results from a randomized chemotherapy study.
International journal of radiation oncology, biology, physics 2002;52(1):128-36.
2002: Kellokumpu-Lehtinen P; Lantto A; Kokko R; Elomaa L; Järvenpää R; Lehtinen R; Blomqvist C
Paclitaxel-ifosfamide for anthracycline-resistant advanced breast cancer.
International journal of clinical pharmacology research 2002;22(2):47-53.
2002: Luoma Minna-Liisa; Hakamies-Blomqvist Liisa; Sjöström Johanna; Mouridsen Hennig; Pluzanska Anna; Malmström Per; Bengtsson Nils Olof; Hultborn Ragnar; Ostenstaad Björn; Mjaaland Ingvil; Valvere Vahur; Wist Erik; Baldursson Gudjon; Ahigren Johan; Blomqvist Carl
Physical performance, toxicity, and quality of life as assessed by the physician and the patient.
Acta oncologica (Stockholm, Sweden) 2002;41(1):44-9.
2001: Vehmanen L; Saarto T; Elomaa I; Mäkelä P; Välimäki M; Blomqvist C
Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment.
European journal of cancer (Oxford, England : 1990) 2001;37(18):2373-8.
2001: Tarkkanen M; Wiklund T A; Virolainen M J; Larramendy M L; Mandahl N; Mertens F; Blomqvist C P; Tukiainen E J; Miettinen M M; Elomaa A I; Knuutila Y S
Comparative genomic hybridization of postirradiation sarcomas.
Cancer 2001;92(7):1992-8.
2001: Eerola H; Pukkala E; Pyrhönen S; Blomqvist C; Sankila R; Nevanlinna H
Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland).
Cancer causes & control : CCC 2001;12(8):739-46.
2001: Hakamies-Blomqvist L; Luoma M L; Sjöström J; Pluzanska A; Sjödin M; Mouridsen H; Østenstad B; Mjaaland I; Ottosson S; Bergh J; Malmström P O; Blomqvist C
Timing of quality of life (QoL) assessments as a source of error in oncological trials.
Journal of advanced nursing 2001;35(5):709-16.
2001: Vahteristo P; Tamminen A; Karvinen P; Eerola H; Eklund C; Aaltonen L A; Blomqvist C; Aittomäki K; Nevanlinna H
p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.
Cancer research 2001;61(15):5718-22.
2001: Eerola H; Vahteristo P; Sarantaus L; Kyyrönen P; Pyrhönen S; Blomqvist C; Pukkala E; Nevanlinna H; Sankila R
Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland.
International journal of cancer. Journal international du cancer 2001;93(3):368-72.
2001: Saarto T; Vehmanen L; Elomaa I; Välimäki M; Mäkelä P; Blomqvist C
The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer.
British journal of cancer 2001;84(8):1047-51.
2001: Vahteristo P; Eerola H; Tamminen A; Blomqvist C; Nevanlinna H
A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.
British journal of cancer 2001;84(5):704-8.
2001: Maula S; Huuhtanen R L; Blomqvist C P; Wiklund T A; Laurila P; Ristamäki R
The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas.
British journal of cancer 2001;84(2):244-52.
2001: Saarto T; Blomqvist C; Virkkunen P; Elomaa I
Adjuvant clodronate treatment does not reduce the frequency of skeletal metastases in node-positive breast cancer patients: 5-year results of a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):10-7.
2001: Sjöström J; Alfthan H; Joensuu H; Stenman U H; Lundin J; Blomqvist C
Serum tumour markers CA 15-3, TPA, TPS, hCGbeta and TATI in the monitoring of chemotherapy response in metastatic breast cancer.
Scandinavian journal of clinical and laboratory investigation 2001;61(6):431-41.
2001: Poikonen P; Blomqvist C; Joensuu H
Effect of obesity on the leukocyte nadir in women treated with adjuvant cyclophosphamide, methotrexate, and fluorouracil dosed according to body surface area.
Acta oncologica (Stockholm, Sweden) 2001;40(1):67-71.
2000: Popov P; Tukiainen E; Asko-Seljaavaara S; Huuhtanen R; Virolainen M; Virkkunen P; Blomqvist C
Soft tissue sarcomas of the lower extremity: surgical treatment and outcome.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2000;26(7):679-85.
2000: Bergh J; Wiklund T; Erikstein B; Lidbrink E; Lindman H; Malmström P; Kellokumpu-Lehtinen P; Bengtsson N O; Söderlund G; Anker G; Wist E; Ottosson S; Salminen E; Ljungman P; Holte H; Nilsson J; Blomqvist C; Wilking N
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.
Lancet 2000;356(9239):1384-91.
2000: Sarantaus L; Huusko P; Eerola H; Launonen V; Vehmanen P; Rapakko K; Gillanders E; Syrjäkoski K; Kainu T; Vahteristo P; Krahe R; Pääkkönen K; Hartikainen J; Blomqvist C; Löppönen T; Holli K; Ryynänen M; Bützow R; Borg A; Wasteson Arver B; Holmberg E; Mannermaa A; Kere J; Kallioniemi O P; Winqvist R; Nevanlinna H
Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.
European journal of human genetics : EJHG 2000;8(10):757-63.
2000: Syrjäkoski K; Vahteristo P; Eerola H; Tamminen A; Kivinummi K; Sarantaus L; Holli K; Blomqvist C; Kallioniemi O P; Kainu T; Nevanlinna H
Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.
Journal of the National Cancer Institute 2000;92(18):1529-31.
2000: Sjöström J; Blomqvist C; Heikkilä P; Boguslawski K V; Räisänen-Sokolowski A; Bengtsson N O; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3103-10.
2000: Hakamies-Blomqvist L; Luoma M; Sjöström J; Pluzanska A; Sjödin M; Mouridsen H; Ostenstad B; Mjaaland I; Ottosson-Lönn S; Bergh J; Malmström P; Blomqvist C
Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group.
European journal of cancer (Oxford, England : 1990) 2000;36(11):1411-7.
2000: Eerola H; Blomqvist C; Pukkala E; Pyrhönen S; Nevanlinna H
Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?
European journal of cancer (Oxford, England : 1990) 2000;36(9):1143-8.
2000: Elomaa I; Blomqvist C P; Saeter G; Akerman M; Stenwig E; Wiebe T; Björk O; Alvegård T A
Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol.
European journal of cancer (Oxford, England : 1990) 2000;36(7):875-80.
2000: Trovik C S; Bauer H C; Alvegård T A; Anderson H; Blomqvist C; Berlin O; Gustafson P; Saeter G; Wallöe A
Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register.
European journal of cancer (Oxford, England : 1990) 2000;36(6):710-6.
2000: Erselcan T; Kairemo K J; Wiklund T A; Hernberg M; Blomqvist C P; Tenhunen M; Bergh J; Joensuu H
Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer.
British journal of cancer 2000;82(4):777-81.
2000: Poikonen P; Saarto T; Elomaa I; Joensuu H; Blomqvist C
Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients.
European journal of cancer (Oxford, England : 1990) 2000;36(1):43-8.
1999: Huuhtanen R L; Wiklund T A; Blomqvist C P; Böhling T O; Virolainen M J; Tribukait B; Andersson L C
A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients.
British journal of cancer 1999;81(6):1017-21.
1999: Skytting B T; Szymanska J; Aalto Y; Lushnikova T; Blomqvist C; Elomaa I; Larsson O; Knuutila S
Clinical importance of genomic imbalances in synovial sarcoma evaluated by comparative genomic hybridization.
Cancer genetics and cytogenetics 1999;115(1):39-46.
1999: Larramendy M L; Mandahl N; Mertens F; Blomqvist C; Kivioja A H; Karaharju E; Valle J; Böhling T; Tarkkanen M; Rydholm A; Akerman M; Bauer H C; Anttila J P; Elomaa I; Knuutila S
Clinical significance of genetic imbalances revealed by comparative genomic hybridization in chondrosarcomas.
Human pathology 1999;30(10):1247-53.
1999: Tarkkanen M; Kiuru-Kuhlefelt S; Blomqvist C; Armengol G; Böhling T; Ekfors T; Virolainen M; Lindholm P; Monge O; Picci P; Knuutila S; Elomaa I
Clinical correlations of genetic changes by comparative genomic hybridization in Ewing sarcoma and related tumors.
Cancer genetics and cytogenetics 1999;114(1):35-41.
1999: Sjöström J; Blomqvist C; Mouridsen H; Pluzanska A; Ottosson-Lönn S; Bengtsson N O; Ostenstad B; Mjaaland I; Palm-Sjövall M; Wist E; Valvere V; Anderson H; Bergh J
Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group.
European journal of cancer (Oxford, England : 1990) 1999;35(8):1194-201.
1999: Poikonen P; Saarto T; Lundin J; Joensuu H; Blomqvist C
Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF.
British journal of cancer 1999;80(11):1763-6.
1999: Elomaa I; Blomqvist C; Saeter G; Nilbert M; Monge O R; Wiebe T; Alvegård T A
Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience.
Acta orthopaedica Scandinavica. Supplementum 1999;285():69-73.
1999: Huuhtanen R L; Blomqvist C P; Böhling T O; Wiklund T A; Tukiainen E J; Virolainen M; Tribukait B; Andersson L C
Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness.
Cancer research 1999;59(12):2885-90.
1999: Jahkola T; Toivonen T; von Smitten K; Virtanen I; Wasenius V M; Blomqvist C
Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors.
British journal of cancer 1999;80(1-2):167-74.
1999: Tarkkanen M; Elomaa I; Blomqvist C; Kivioja A H; Kellokumpu-Lehtinen P; Böhling T; Valle J; Knuutila S
DNA sequence copy number increase at 8q: a potential new prognostic marker in high-grade osteosarcoma.
International journal of cancer. Journal international du cancer 1999;84(2):114-21.
1999: Tasmuth T; Blomqvist C; Kalso E
Chronic post-treatment symptoms in patients with breast cancer operated in different surgical units.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1999;25(1):38-43.
1999: Huuhtanen R L; Blomqvist C P; Wiklund T A; Böhling T O; Virolainen M J; Tukiainen E J; Tribukait B; Andersson L C
Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma.
British journal of cancer 1999;79(5-6):945-51.
1999: Lindman H; Wiklund T; Holte H; Ljungman P; Blomqvist C; Kvalheim G; Bengtsson M; Höglund M; Wilking N; Bergh J
FEC mobilized stem cells for high-dose therapy in breast cancer patients. SB6 9401 Study Group.
Acta oncologica (Stockholm, Sweden) 1999;38(2):239-45.
1998: Jahkola T; Toivonen T; Virtanen I; von Smitten K; Nordling S; von Boguslawski K; Haglund C; Nevanlinna H; Blomqvist C
Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.
British journal of cancer 1998;78(11):1507-13.
1998: Sjöström J; Krajewski S; Franssila K; Niskanen E; Wasenius V M; Nordling S; Reed J C; Blomqvist C
A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer.
British journal of cancer 1998;78(6):812-5.
1998: Saarto T; Blomqvist C; Risteli J; Risteli L; Sarna S; Elomaa I
Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients.
British journal of cancer 1998;78(2):240-5.
1998: Tasmuth T; von Smitten K; Blomqvist C; Kalso E
[Chronic pain and other symptoms following treatment of breast cancer]
Duodecim; lääketieteellinen aikakauskirja 1998;114(1):52-4.
1997: Kajanti M; Blomqvist C; Lehtonen H; Kouri M; Wiklund T; Holsti L R
Biweekly dose escalation in curative accelerated hyperfractionation for advanced head and neck cancer: a feasibility study.
International journal of radiation oncology, biology, physics 1997;39(4):837-40.
1997: Szymanska J; Virolainen M; Tarkkanen M; Wiklund T; Asko-Seljavaara S; Tukiainen E; Elomaa I; Blomqvist C; Knuutila S
Overrepresentation of 1q21-23 and 12q13-21 in lipoma-like liposarcomas but not in benign lipomas: a comparative genomic hybridization study.
Cancer genetics and cytogenetics 1997;99(1):14-8.
1997: Larramendy M L; Tarkkanen M; Blomqvist C; Virolainen M; Wiklund T; Asko-Seljavaara S; Elomaa I; Knuutila S
Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker.
The American journal of pathology 1997;151(4):1153-61.
1997: Saarto T; Blomqvist C; Välimäki M; Mäkelä P; Sarna S; Elomaa I
Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1341-7.
1997: Wiklund T; Saeter G; Strander H; Alvegård T; Blomqvist C
The outcome of advanced soft tissue sarcoma patients with complete tumour regression after either chemotherapy alone or chemotherapy plus surgery. The Scandinavian Sarcoma Group experience.
European journal of cancer (Oxford, England : 1990) 1997;33(3):357-61.
1997: Wolf M; Aaltonen L A; Szymanska J; Tarkkanen M; Blomqvist C; Berner J M; Myklebost O; Knuutila S
Complexity of 12q13-22 amplicon in liposarcoma: microsatellite repeat analysis.
Genes, chromosomes & cancer 1997;18(1):66-70.
1997: Tasmuth T; Kataja M; Blomqvist C; von Smitten K; Kalso E
Treatment-related factors predisposing to chronic pain in patients with breast cancer--a multivariate approach.
Acta oncologica (Stockholm, Sweden) 1997;36(6):625-30.
1997: Muhonen T; Eerola H; Vehmanen P; Nevanlinna H; Aktan K; Blomqvist C; Kääriäinen H; Pyrhönen S
Breast cancer risk estimation in families with history of breast cancer.
British journal of cancer 1997;76(9):1228-31.
1997: Niskanen E; Blomqvist C; Franssila K; Hietanen P; Wasenius V M
Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.
British journal of cancer 1997;76(7):917-22.
1997: Blomqvist C; von Boguslawski K; Stenman U H; Mäenpää H; von Smitten K; Nordling S
Long-term prognostic impact of immunohistochemical estrogen receptor determinations compared with biochemical receptor determination in primary breast cancer.
Acta oncologica (Stockholm, Sweden) 1997;36(5):530-2.
1997: Armengol G; Tarkkanen M; Virolainen M; Forus A; Valle J; Böhling T; Asko-Seljavaara S; Blomqvist C; Elomaa I; Karaharju E; Kivioja A H; Siimes M A; Tukiainen E; Caballín M R; Myklebost O; Knuutila S
Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization.
British journal of cancer 1997;75(10):1403-9.
1997: Saarto T; Blomqvist C; Välimäki M; Mäkelä P; Sarna S; Elomaa I
Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens.
British journal of cancer 1997;75(4):602-5.
1997: Saarto T; Blomqvist C; Rissanen P; Auvinen A; Elomaa I
Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer.
British journal of cancer 1997;75(2):301-5.
1996: Jahkola T; Toivonen T; von Smitten K; Blomqvist C; Virtanen I
Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis.
International journal of cancer. Journal international du cancer 1996;69(6):445-7.
1996: Saarto T; Blomqvist C; Ehnholm C; Taskinen M R; Elomaa I
Effects of chemotherapy-induced castration on serum lipids and apoproteins in premenopausal women with node-positive breast cancer.
The Journal of clinical endocrinology and metabolism 1996;81(12):4453-7.
1996: Mäenpää H; Blomqvist C; Wiklund T; Lehtonen T; Elomaa I
Results of treatment in testicular nonseminoma.
Annals of medicine 1996;28(4):311-4.
1996: Blomqvist C; Huuhtanen R; Pan Y; Wiklund T; Tarkkanen M; Virolainen M; Tribukait B
Growth rate of lung metastases and S-phase fraction as determined by flow cytometry from the primary tumour in 25 patients with bone or soft-tissue sarcomas.
British journal of cancer 1996;73(12):1556-9.
1996: Muhonen T; Jantunen I; Pertovaara H; Voutilainen L; Maiche A; Blomqvist C; Pyrhönen S; Kellokumpu-Lehtinen P
Prophylactic filgrastim (G-CSF) during mitomycin-C, mitoxantrone, and methotrexate (MMM) treatment for metastatic breast cancer. A randomized study.
American journal of clinical oncology 1996;19(3):232-4.
1996: Huuhtanen R L; Blomqvist C P; Wiklund T A; Virolainen M J; Elomaa A I; Pan Y; Tribukait B
S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome.
Cancer 1996;77(9):1815-22.
1996: Blomqvist C; Risteli L; Risteli J; Virkkunen P; Sarna S; Elomaa I
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.
British journal of cancer 1996;73(9):1074-9.
1996: Kairemo K J; Blomqvist C P; Miettinen M
Cardiac myxomas.
The New England journal of medicine 1996;334(21):1407-8; author reply 1408-9.
1996: Szymanska J; Tarkkanen M; Wiklund T; Virolainen M; Blomqvist C; Asko-Seljavaara S; Tukiainen E; Elomaa I; Knuutila S
Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization.
Genes, chromosomes & cancer 1996;15(2):89-94.
1996: Wiklund T; Huuhtanen R; Blomqvist C; Tukiainen E; Virolainen M; Virkkunen P; Asko-Seljavaara S; Björkenheim J M; Elomaa I
The importance of a multidisciplinary group in the treatment of soft tissue sarcomas.
European journal of cancer (Oxford, England : 1990) 1996;32A(2):269-73.
1996: Saarto T; Blomqvist C; Ehnholm C; Taskinen M R; Elomaa I
Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):429-33.
1996: Szymanska J; Tarkkanen M; Wiklund T; Virolainen M; Blomqvist C; Asko-Seljavaara S; Tukiainen E; Elomaa I; Knuutila S
Cytogenetic study of extraskeletal mesenchymal chondrosarcoma. A case report.
Cancer genetics and cytogenetics 1996;86(2):170-3.
1996: Wiklund T; Blomqvist C; Risteli L; Risteli J; Karaharju E; Elomaa I
Type I and type III collagen metabolites in adult osteosarcoma patients.
British journal of cancer 1996;73(1):106-9.
1996: Kouri M; Kajanti M; Blomqvist C; Tenhunen M; Minn H
[Recent advances in radiation oncology]
Duodecim; lääketieteellinen aikakauskirja 1996;112(18):1715-22.
1996: Sjöström J; Blomqvist C
Predictive factors for response to cytotoxic treatment in advanced breast cancer: a review.
Acta oncologica (Stockholm, Sweden) 1996;35 Suppl 5():84-90.
1996: Blomqvist C; Elomaa I
Bisphosphonate therapy in metastatic breast cancer.
Acta oncologica (Stockholm, Sweden) 1996;35 Suppl 5():81-3.
1995: Blomqvist C; Hietanen P; Teerenhovi L; Rissanen P
Vinorelbine and epirubicin in metastatic breast cancer. A dose finding study.
European journal of cancer (Oxford, England : 1990) 1995;31A(13-14):2406-8.
1995: Szymanska J; Tarkkanen M; Wiklund T; Virolainen M; Blomqvist C; Asko-Seljavaara S; Tukiainen E; Elomaa I; Knuutila S
A cytogenetic study of malignant fibrous histiocytoma.
Cancer genetics and cytogenetics 1995;85(2):91-6.
1995: Hietanen P; Blomqvist C; Wasenius V M; Niskanen E; Franssila K; Nordling S
Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?
British journal of cancer 1995;71(5):1029-32.
1995: Saarto T; Blomqvist C; Tiusanen K; Gröhn P; Rissanen P; Elomaa I
The prognosis of stage III breast cancer treated with postoperative radiotherapy and adriamycin-based chemotherapy with and without tamoxifen. Eight year follow-up results of a randomized trial.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(2):146-50.
1995: Blomqvist C; Wiklund T; Pajunen M; Virolainen M; Elomaa I
Oral trofosfamide: an active drug in the treatment of soft-tissue sarcoma.
Cancer chemotherapy and pharmacology 1995;36(3):263-5.
1995: Elomaa I; Blomqvist C
Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancy.
Acta oncologica (Stockholm, Sweden) 1995;34(5):629-36.
1995: Joensuu T K; Blomqvist C P; Kajanti M J
Primary radiation therapy in the treatment of localized prostatic cancer.
Acta oncologica (Stockholm, Sweden) 1995;34(2):183-91.
1994: Porkka K; Blomqvist C; Rissanen P; Elomaa I; Pyrhönen S
Salvage therapies in women who fail to respond to first-line treatment with fluorouracil, epirubicin, and cyclophosphamide for advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1639-47.
1994: Taube T; Elomaa I; Blomqvist C; Beneton M N; Kanis J A
Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer.
Bone 1994;15(2):161-6.
1993: Blomqvist C; Wiklund T; Tarkkanen M; Elomaa I; Virolainen M
Measurement of growth rate of lung metastases in 21 patients with bone or soft-tissue sarcoma.
British journal of cancer 1993;68(2):414-7.
1993: Blomqvist C; Elomaa I; Rissanen P; Hietanen P; Nevasaari K; Helle L
Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administration.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):467-73.
1993: Wiklund T A; Blomqvist C P; Risteli L; Risteli J; Elomaa I
Impact of chemotherapy on collagen metabolism: a study of serum PIIINP (aminoterminal propeptide of type III procollagen) in advanced sarcomas.
Journal of cancer research and clinical oncology 1993;119(3):160-4.
1993: Wiklund T A; Alvegård T A; Mouridsen H T; Rydholm A; Blomqvist C P
Marginal surgery and postoperative radiotherapy in soft tissue sarcomas. The Scandinavian Sarcoma Group experience.
European journal of cancer (Oxford, England : 1990) 1993;29A(3):306-9.
1993: Taube T; Elomaa I; Blomqvist C; Beneton M N; Kanis J A
Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: a histomorphometric study.
European journal of cancer (Oxford, England : 1990) 1993;29A(12):1677-81.
1992: Blomqvist C; Tiusanen K; Elomaa I; Rissanen P; Hietanen T; Heinonen E; Gröhn P
The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial.
British journal of cancer 1992;66(6):1171-6.
1992: Blomqvist C P; Elomaa I; Rissanen P
Adjuvant hormone therapy in breast cancer.
Annals of medicine 1992;24(2):91-6.
1992: Wiklund T A; Elomaa I; Blomqvist C P; Risteli L; Risteli J
Type III collagen metabolism in soft tissue sarcomas.
British journal of cancer 1992;65(2):193-6.
1992: Blomqvist C; Elomaa I; Rissanen P; Hietanen P; Nevasaari K; Helle L
FEC (5-fluorouracil-epirubicin-cyclophosphamide) monthly versus FEC weekly in metastatic breast cancer. First results of a randomized trial.
Acta oncologica (Stockholm, Sweden) 1992;31(2):231-6.
1992: Wiklund T A; Blomqvist C P; Virolainen M; Elomaa I
Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma.
Cancer chemotherapy and pharmacology 1992;30(2):100-4.
1992: Muhonen T T; Wiklund T A; Blomqvist C P; Pyrhönen S O
Unexpected prolonged myelosuppression after mitomycin, mitoxantrone and methotrexate.
European journal of cancer (Oxford, England : 1990) 1992;28A(12):1974-6.
1991: Wiklund T A; Blomqvist C P; Räty J; Elomaa I; Rissanen P; Miettinen M
Postirradiation sarcoma. Analysis of a nationwide cancer registry material.
Cancer 1991;68(3):524-31.
1990: Elomaa I; Siimes M A; Blomqvist C; Karaharju E; Ryöppy S; Laasonen E; Holmström T
Ten years' experience in patients with osteogenic sarcoma in Finland.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1990;16(2):147-52.
1990: Kairemo K J; Wiklund T A; Liewendahl K; Miettinen M; Heikkonen J J; Virkkunen P J; Aronen H J; Blomqvist C P
Imaging of soft-tissue sarcomas with indium-111-labeled monoclonal antimyosin Fab fragments.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(1):23-31.
1989: Alvegård T A; Sigurdsson H; Mouridsen H; Solheim O; Unsgaard B; Ringborg U; Dahl O; Nordentoft A M; Blomqvist C; Rydholm A
Adjuvant chemotherapy with doxorubicin in high-grade soft tissue sarcoma: a randomized trial of the Scandinavian Sarcoma Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(10):1504-13.
1989: Elomaa I; Blomqvist C; Porkka L; Holmström T
Experiences of clodronate treatment of multifocal eosinophilic granuloma of bone.
Journal of internal medicine 1989;225(1):59-61.
1988: Elomaa I; Taube T; Blomqvist C; Rissanen P; Rannikko S; Alfthan O
Aminoglutethimide for advanced prostatic cancer resistant to conventional hormonal therapy.
European urology 1988;14(2):104-6.
1988: Blomqvist C; Elomaa I; Porkka L; Karonen S L; Lamberg-Allardt C
Evaluation of salmon calcitonin treatment in bone metastases from breast cancer--a controlled trial.
Bone 1988;9(1):45-51.
1988: Elomaa I; Blomqvist C; Rissanen P
Weekly low-dose doxorubicin as second line therapy in advanced breast cancer.
Acta oncologica (Stockholm, Sweden) 1988;27(6b):799-801.
1988: Elomaa I; Blomqvist C; Porkka L; Holmström T; Taube T; Lamberg-Allardt C; Borgström G H
Clodronate for osteolytic metastases due to breast cancer.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1988;42(2):111-6.
1988: Elomaa I; Blomqvist C; Rissanen P; Mäntylä M
Weekly low-dose doxorubicin with or without high-dose medroxyprogesterone acetate as secondary treatment in metastatic breast cancer--a randomized trial.
Acta oncologica (Stockholm, Sweden) 1988;27(3):297-9.
1987: Blomqvist C; Elomaa I; Virkkunen P; Porkka L; Karonen S L; Risteli L; Risteli J
The response evaluation of bone metastases in mammary carcinoma. The value of radiology, scintigraphy, and biochemical markers of bone metabolism.
Cancer 1987;60(12):2907-12.
1987: Elomaa I; Blomqvist C; Porkka L; Lamberg-Allardt C; Borgström G H
Treatment of skeletal disease in breast cancer: a controlled clodronate trial.
Bone 1987;8 Suppl 1():S53-6.
1987: Borgström G H; Elomaa I; Blomqvist C; Porkka L
Cytogenetic investigations of patients on clodronate therapy for Paget's disease of bone.
Bone 1987;8 Suppl 1():S85-6.
1985: Elomaa I; Blomqvist C; Porkka L; Holmström T; Taube T; Lamberg-Allardt C; Borgström G H
Diphosphonates for osteolytic metastases.
Lancet 1985;1(8438):1155-6.
1984: Elomaa I; Blomqvist C; Porkka L; Holmström T; Laine H
Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism.
Cancer treatment reports 1984;68(4):655-7.
1983: Elomaa I; Blomqvist C; Gröhn P; Porkka L; Kairento A L; Selander K; Lamberg-Allardt C; Holmström T
Long-term controlled trial with diphosphonate in patients with osteolytic bone metastases.
Lancet 1983;1(8317):146-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Carl Blomqvist

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Carl Blomqvist (preview)

All Publications